More Volatile Trading Ahead for Weed Inc (OTCMKTS:BUDZ)

More Volatile Trading Ahead for Weed Inc (OTCMKTS:BUDZ)

SHARE

Weed Inc (OTCMKTS:BUDZ) has seen a small bump upward this week, even with some rocky trading this afternoon. BUDZ recently acquired property for its bioscience center in Southern Colorado. Sangre AgroTech, BUDZ’s subsidiary, has begun its 5-Year, $15+ million Cannabis Genomic Study to complete a global genomic classification of the Cannabis plant genus.

Doug Brgoch, the Mayor of La Veta, Colorado, said, “I cannot tell you how happy I am to have Sangre AgroTech join our community. The locating of the company to La Veta, I believe, will mean a great boost for the town’s economy and financial stability for our municipal government. The local school district will benefit through increased taxes, and Huerfano County will also feel a positive impact. This enterprise is exactly what I hoped would come to our town. I can’t wait to see what evolves.”

Weed Inc (OTCMKTS:BUDZ) promulgates itself as a company that seeks to pursue full legalization of cannabis across America through a legal taxation with representation format.

The company is a USA-based public firm. WEED Inc. is a multi-national, multi-faceted, vertically-integrated world class Cannabis organization. WEED is structured as a holding company doing business through its divisions, wholly-owned subsidiaries, and strategically placed collaborative partners to achieve and promote our global brand.

WEED is dedicated to its global goals and outreach across the full spectrum of the Cannabis industry to find treatments and medical cures utilizing the Cannabaceae plant family. WEED does not grow, harvest, produce, or sell any substance in violation of US Federal law under The Federal Controlled Substances Act, and meets all standards of international law in the countries that WEED does business in.

According to company materials, “is a public company, trading on the Over The Counter quotation system. Investors and shareholders may view WEEDS stock info at OTCMarkets,com  WEED will focus on purchasing land and building Commercial Grade “Cultivation Centers” to consult, assist, manage & lease to Licensed Dispensary owners and organic grow operators  on a contract basis, with a concentration on the legal and medical marijuana sector. Once cleared off the Schedule 1 of the Controlled Substance Act. WEED will look to purchase and/or establish its own wholesale/retail outlets. “RESEARCH is the KEY to the FUTURE”. To that effect WEED will open a Research Center in Perth Australia in Q1 2016.”

The company is run by its Founder and CEO Glenn E. Martin who has 46 years of advocacy and research in the cannabis space. The company’s goal is to create the highest quality cannabis agricultural centers that will raise the bar for the entire industry.

Subscribe below and we’ll keep you on top of what’s happening before $BUDZ stock makes its next move.

BUDZ has taken a serious hit after the election and never really receovered. The stock has leveled off through the summer and the new workspace for Sangre Agro could mean another injection of life is possible.

Glenn E. Martin, CEO of WEED, Inc., stated, “The purchase of the Le Veta property is an important step to allow Sangre AgroTech to have a state-of-the-art facility to conduct its Cannabis genomic research and is a building block for WEED’s larger, global strategy of creating a vertically-integrated cannabis business. WEED is also happy to be a part of the greater La Veta community and plans to make a positive impact in the surrounding area and the State of Colorado in the years to come.”

Weed Inc (OTCMKTS:BUDZ) has certainly had a rough summer, but it could have been worse. There might be daylight ahead for BUDZ, but the stock needs to be more than just a nice ticker symbol in order to truly make up ground. BUDZ has a $125.99M market cap and 99.99M shares out. For continuing coverage on shares of $BUDZ stock, as well as our other hot stock picks, sign up for our free newsletter today and get our next hot stock pick!

Disclosure: We hold no position in $BUDZ, either long or short, and we have not been compensated for this article.

Sign Up for our 100% FREE Oracle Dispatch Newsletter